Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III …Equities.comSUNNYVALE, Calif., Oct. 15, 2012 /PRNewswire/ — Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international, randomized Phase III clinical trial …
CE Mark for Rapid Acute Kidney Injury Test – Genetic Engineering News
CE Mark for Rapid Acute Kidney Injury TestGenetic Engineering NewsAstute Medical's NephroCheck™ test has received a CE mark for commercialization in Europe. The cartridge-based sandwich immunoassay test, run on the firm's Astute140™ Meter, …
Pharmacyclics gets $50M milestone payment from J&J – MarketWatch
Pharmacyclics gets $50M milestone payment from J&JMarketWatchThe trial involves Pharmacyclics's drug ibrutinib in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocy…
Apollo Group organises CME on contemporary developments in transplant … – pharmabiz.com
Apollo Group organises CME on contemporary developments in transplant …pharmabiz.comThe main aim of the CME programme is to deliver a series of stimulating, interactive and practical learning experiences via lectures and case-centric discussions base…
Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III … – Sacramento Bee
Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III …Sacramento BeeSUNNYVALE, Calif., Oct. 15, 2012 — /PRNewswire/ — Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international, randomized Phase III clinical t…
Intercept Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
NEW YORK — Intercept Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced …
Biogen sees bright future in MS combo therapies – Pharma Times
Biogen sees bright future in MS combo therapiesPharma TimesHe also highlighted the progress being made on a pegylated version of its blockbuster Avonex (interferon beta-1a) and Abbott-partnered daclizumab,. Asked which of the current pipeline compounds…
Sexy Singer's 'Ringa Ringa' Special – Times of India
Sexy Singer's 'Ringa Ringa' SpecialTimes of IndiaWe have this program called 'Open Heart With RK', where ABN MD Radha Krishna shocks the guests with his straight forward questions and honest talks. As part of the channels 3rd annive…
Non-surgical angioplasty answer to heart trouble – Times of India
Non-surgical angioplasty answer to heart troubleTimes of IndiaEvolving technology and newer techniques make doctors opt for angioplasty while treating complicated heart disease. Recently, a prominent political leader's heart condition sparked off a…
Sitting for long periods doubles risk of death – Times of India
Sitting for long periods doubles risk of deathTimes of IndiaBy simply limiting the time that we spend sitting, we may be able to reduce our risk of diabetes, heart disease and death," said Dr Wilmot, a Clinical Research Fellow in Diabetes and Endo…